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Background: Although over 60 non-syndromic deafness genes have been identified to date, the etiologic
contribution of most deafness genes remained elusive. In this study, we addressed this issue by targeted
next-generation sequencing of a large cohort of non-syndromic deaf probands.
Methods: Probands with mutations in commonly screened deafness genes GJB2, SLC26A4 and MT-RNR1 were
pre-excluded by Sanger sequencing. The remaining 125 deaf probands proceeded through targeted exon
capturing of 79 known deafness genes and Illumina HiSeq2000 sequencing.
Results: Bi-allelic mutations in 15 less commonly screened deafness genes were identified in 28 deaf probands,
with mutations in MYO15A, GPR98, TMC1, USH2A and PCDH15 being relatively more frequent (≥3 probands each).
Dominant mutations in MYO6, TECTA, POU4F3 and COCH were identified in 4 deaf families. A mitochondrial MTTS1
mutation was identified in one maternally inherited deaf family. No pathogenic mutations were identified in three
dominant deaf families and two consanguineous families.
Conclusions: Mutations in the less commonly screened deafness genes were heterogeneous and contributed to a
significant percentage (17.4%) of causes for non-syndromic deafness. Targeted next-generation sequencing
provided a comprehensive and efficient diagnosis for known deafness genes. Complementary to linkage analysis or
whole-exome sequencing of deaf families, pre-exclusion of known deafness genes by this strategy may facilitate
the discovery of novel deafness genes.
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Hearing impairment, or deafness in its most severe form,
is the most common sensory disorder in humans. One
in a thousand children develops congenital or prelingual
deafness. Another one in a thousand children becomes
deaf or severely hearing impaired before adulthood [1].
It was estimated that at least 50% to 60% of childhood
hearing impairment was caused by genetic factors [2].
Among them, approximately 70% of cases are non-
syndromic, meaning the hearing impairment is the only* Correspondence: wuhao622@sina.cn
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reproduction in any medium, provided the ordistinctive clinical feature, and the remaining 30% are
syndromic with other abnormalities [3].
Identifying the genetic basis of deafness provides cru-
cial information for diagnosis, intervention and treat-
ment of the disease. The causes, however, are extremely
heterogeneous. To date, mutations in 64 genes have
been found to be associated with non-syndromic deaf-
ness (Hereditary Hearing Loss Homepage, http://
webh01.ua.ac.be/hhh/). Most of those genes were origin-
ally identified through the linkage analysis of single or
multiple deaf families. Expanded screening in large co-
horts revealed that mutations in three genes, GJB2,
SLC26A4 and MT-RNR1, were commonly found in deaf
patients. In Chinese Hans, for example, bi-allelic GJB2
mutations were reported in 19.1% of patients with non-
syndromic deafness, followed by bi-allelic SLC26A4d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tation of MT-RNR in 1.6% [4-6]. These genes have been
routinely screened during genetic testing and counseling
of deafness.
On the other side, the causes remained unknown for
majority of deaf individuals. The etiologic contribution
of the less commonly screened deafness genes, in par-
ticular, has yet to be investigated systematically. Due to
the large number and presumably low mutation frequen-
cies of those genes, it would be highly expensive and
time-consuming to address this issue by the conven-
tional gene-by-gene Sanger sequencing. This limitation,
however, may be overcome by the targeted next-
generation sequencing (NGS) technologies. With ge-
nomic capturing of a wide array of known deafness
genes, it is possible to screen those genes in high
throughput by NGS. The feasibility of this strategy has
been confirmed in principle in several pilot studies [7-9].
In this study, we performed a comprehensive mutations
screening of 79 deafness genes in a large cohort of non-
syndromic deaf probands using the targeted NGS. Our
results provided a preliminary overview of the genetic
etiology of non-syndromic deafness in Chinese Hans.
Methods
Recruitment of the subjects
Non-syndromic deaf probands were recruited from deaf
patients seeking genetic testing and counseling in
Xinhua Hospital, Shanghai, China. Family history and
clinical questionnaire was obtained from all subjects or
their parents. Physical and neurological examination was
performed with special attention to renal, electrocardiac
and ophthalmologic differences to exclude those with
syndromic deafness. A comprehensive auditory evalu-
ation was performed including otoscope examination,
tympanometry, pure-tone audiometry (PTA), auditory
brainstem response (ABR) in subjects with very young
age, and in some cases computed tomography (CT) of
the inner ear. The onset of hearing impairment was cate-
gorized as prelingual/early (≤ 6 years) and late (> 6 years).
PTA was calculated as the average of the hearing level at
0.5, 1.0, 2.0 and 4.0 KHz for the better ear. The severity
of hearing impairment was defined as mild (20~40 dB),
moderate (41–70 dB), severe (71~95 dB) and profound
(>95 dB). To enroll in this study, all probands should
have bilateral, permanent sensorineural hearing impair-
ment. The hearing level of the prelingual or early-onset
deaf probands should exceed 70 dB. For the late-onset,
progressive probands, their hearing level should exceed
40 dB at the age of 35 years. All subjects or their par-
ents gave written, informed consent to participate in this
study. This study was approved by the Ethics Committee
of the Shanghai Jiaotong University School of Medicine,
Xinhua Hospital.Pre-exclusion of mutations in common deafness genes
All deaf probands (n=190) were pre-screened against
common deafness genes GJB2, SLC26A4 and MT-RNR1
by PCR amplification and bidirectional sequencing as
previously described [4-6]. A total of 125 deaf probands
were void of mutations in the three common deafness
genes and proceeded through the targeted exon captur-
ing and NGS.
Targeted genomic capturing and next-generation
sequencing
A customized capture array (NimbleGen, Roche) was de-
signed to capture all exons, splicing sites and immediate
flanking intron sequences of 79 deafness genes (Additional
file 1: Table S1) as previously described [10]. Genomic
DNA were extracted from the blood samples using the
Blood DNA kit (TIANGEN BIOTECH, Beijing, China)
and fragmented to 200–300 base pairs using an ultra-
sonoscope (Covaris S2, Massachusetts, USA). End-repair,
adenylation and adapter ligation were performed for li-
brary preparation following standard Illumina protocols.
Targeted DNA fragments were captured by hybridization
to the capture array and sequenced on Illumina
HiSeq2000 Analyzers for 90 cycles per read. Image ana-
lysis, error estimation and base calling were performed
using the Illumina Pipeline (version 1.3.4).
Data analysis and bioinformatics processing were per-
formed as previously described [10]. Reads were aligned
to NCBI37/hg19 assembly using the BWA Multi-Vision
software package. SNPs and indels were identified using
the SOAPsnp software and the GATK Indel Genotyper,
respectively. Previously identified SNPs and their allele
frequencies were determined using the NCBI dbSNP,
1000 Genomes and the in-house sequencing data of 200
Chinese Han normal hearing controls.
Confirmation of the potential mutations
Potential mutations detected by targeted NGS were veri-
fied by PCR amplification and Sanger sequencing in corre-
sponding probands. For multiplex probands, segregation
of the variants with the deaf phenotype was also verified
in extended family members when available. The strength
of the ectopic splicing sites created by two intronic vari-
ants was evaluated by the Human Splicing Finder program
(http://www.umd.be/HSF/). Possible pathogenic effects of
the missense mutations were evaluated by the Mutation
Taster (http://www.mutationtaster.org), PROVEAN and
SIFT (with cut-off scores set at −1.3 and 0.05, respectively,
http://sift.jcvi.org) programs.
Results
Characterization of the deaf probands
A total of 190 probands with non-syndromic deafness
was recruited in our study, including 137 simplex and 53
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from dominant deaf families; four from maternally
inherited deaf families; forty-two had at least one first-
or second-degree deaf relative and were consistent with
a possible recessive inheritance.
Clinical information of the deaf probands was summa-
rized in Table 1. The ages of the probands varied be-
tween a few months to over 50 years (mean 14.0 years,
95% CI 11.8-16.3 years). The 7 dominant probands had
late-onset, progressive, moderate-to-severe sensorineural
hearing impairment. All other probands had prelingual
or early-onset, severe-to-profound sensorineural hearing
impairment.
Pre-screening of the common deafness genes
Pre-screening of mutations in three common deafness
genes, GJB2, SLC26A4 and MT-RNR1, was performed in
all 190 deaf probands by Sanger sequencing. Bi-allelic
mutations in GJB2 and SLC26A4 and the homoplasmic
A1555G mutation of MT-RNR1 were detected in 36, 22
and 7 probands, respectively (Additional file 2: Table
S2). Those probands were excluded from further scree-
ning by targeted NGS.
Targeted NGS sequencing of known deafness genes
The remaining 125 deaf probands, including 93 simplex












Male 84 19 4 1
Female 53 23 3 3
Age at the test
0-6 years 44 22 0 0
6-18 years 66 5 1 1
18-35years 23 15 0 3




137 42 0 4
Late onset
(> 6 years)
0 0 7 0
Severity of hearing
impairment
Mild 0 0 0 0
Moderate 0 0 4 0
Severe 64 15 3 3
Profound 73 27 0 1proband and 24 multiplex probands with presumably re-
cessive inheritance went through targeted NGS screen-
ing of 79 deafness genes (Additional file 1: Table S1).
Included in the list were 50 non-syndromic deafness
genes (24 autosomal recessive, 17 autosomal dominant,
6 autosomal recessive/dominant, 2 X-linked and 1 mito-
chondrial), 7 non-syndromic/syndromic deafness genes
(4 autosomal recessive, 2 autosomal recessive/dominant
and 1 mitochondrial) and 22 syndromic deafness genes.
A total of 1496 exons, 340995 bases (233790 bases in
coding regions and 107205 bases in flanking intronic
and untranslated regions) were captured and sequenced
in our study. After alignment to the reference human
genome (NCBI37/hg19), 47.28% of the clean reads could
be uniquely matched to the targeted regions. The ave-
rage depth for the targeted regions was 293.21-fold.
99.35% of the targeted regions were covered by 20 or
more reads, demonstrating the high quality of the
sequencing.
Mutation identification and verification
Hundreds of variants of high sequencing quality were
detected in each proband. To identify the most likely
pathogenic mutations, we filtered out: 1) all previously
identified SNPs with allele frequencies of 0.005 or
higher, 2) synonymous variants in the coding region and
3) variants in the intronic or untranslated regions (with
the exception of the splicing site mutations or variants
that may create an ectopic splicing site).
In 7 dominant probands, we identified 7 heterozygous,
non-synonymous variants. None of them was found in
200 ethnically-matched normal hearing controls. Four of
them were found co-segregating with the deaf phenotype
in extended family members. In addition, a homoplasmic
mitochondrial variant was identified in a maternally
inherited deaf family with reduced penetrance (Table 2
and Figure 1). Among the five candidate mutations,
T7511C in MT-TS1 and p.C1509G in TECTA have been
reported to be associated with non-syndromic deafness
in previous studies [11-14]. For the other three novel
mutations, p.Q982X in MYO6 and c.603_604delGG in
POU4F3 were predicted to lead to a prematurely
stopped protein, while p.G87V in COCH changed an
evolutionarily conserved amino acid (PhyloP score: 4.75)
and was unanimously predicted to be disease-causing by
the Mutation Taster, PROVEAN and SIFT programs.
Our results suggested that these five mutations in
MYO6, TECTA, POU4F3, COCH and MTTS1 were
pathogenic.
A total of 254 non-synonymous or splicing site vari-
ants were identified in 117 simplex or recessive multi-
plex probands with allele frequencies of 0.0025 or lower
(Additional file 3: Table S3). Consistent with the reces-
sive inheritance, 48 candidate mutations in 15 deafness
Table 2 Mutations identified in deaf families with dominant or maternal inheritance


















D372 MYO6 Nonsense c.2944C>T p.Q982X - DCd - - 0 Novel
D385 TECTA Missense c.4525T>G p.C1509G 4.762 DC DC (−9.54) DC (0.004) 0 Reported [12]
D882 COCH Missense c.260G>T p.G87V 4.748 DC DC (−5.63) DC (0.000) 0 Novel
P59 POU4F3 Frame shift c.603_604delGG - - DC - - 0 Novel
D1037 MTTS1 Mitochondrial T7511C - - DC - - 0 Reported [13,14]
aScore ranges from −14 (not conserved) to 6 (conserved); bNegative and positive scores indicate deleterious and neutral, respectively, with cut-off score set at
−1.3; cScore ranges from 0 (deleterious) to 1 (neutral), with cut-off score set at 0.05. dDC: Disease causing.
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compound heterozygotes (22 probands, Table 3). Three
of them, p.R2728H in MYO15A, p.R445H and c.150delT
in TMC1, have been previously reported to be associated
with non-syndromic deafness [8,15,16]. Among the other
45 novel candidate mutations, sixteen were nonsense
mutations, frame-shifting indels or splicing site muta-
tions. In addition, two intronic variants, c.6956+9C>G in
MYO15A and c.4961-3C>G in OTOF, were predicted to
create a strong ectopic splicing site (HSF score of 80.6
and 75.0, respectively) by the Human Splicing Finder
program. These 18 mutations were predicted to lead to
a significantly truncated protein product. For the
remaining 25 missense variants and 2 in-frame deletions,
all of them changed evolutionarily conserved amino
acids with positive PhyloP scores and were predicted to
be disease-causing by at least one of the Mutation
Taster, PROVEAN and SIFT programs. Nineteen of 25
missense mutations were unanimously predicted to be
disease-causing by all three programs. None of the 48
candidate mutations were found in the 200 Chinese Han
normal hearing controls. For 9 multiplex probands
(noted with asterisks in Table 3), the bi-allelic mutations
were also found in their deaf relatives. Based on these
results, the 48 recessive candidate mutations were highly
likely to be pathogenic.
Overall, our targeted NGS screening identified one
mitochondrial mutation in MTTS1 and four dominant
mutations in MYO6, TECTA, POU4F3 and COCH each.
For recessive deafness genes, bi-allelic mutations were
identified in 19 simplex and 9 multiplex probands, re-
spectively. Mutations in MYO15A were most frequently
detected (5/125), followed by mutations in USH2A,
PCDH15, GPR98, TMC1 (3/125 each), CDH23 (2/125),
OTOF, MYO7A, ESRRB, MARVELD2, TECTA, WHRN,
MYO6, PTPRQ and POU3F4 (1/125 each).
Discussion
We investigated the genetic epidemiology of non-
syndromic deafness in the present study. Like most deaf
patients seeking genetic testing and counseling, the ma-
jority of our subjects (179/190) were simplex or recessivemultiplex probands with non-syndromic, prelingual or
early-onset, severe-to-profound hearing impairment. Un-
like the syndromic deafness or the progressive, late-onset
hearing impairment with representative audioprofiles, this
type of hearing impairment is extremely heterogeneous
and was often difficult to determine the genetic causes.
We attempted to solve this problem by targeted NGS
screening of 79 deafness genes, including all known 57
non-syndromic deafness genes at the time when this
study was designed. An additional 22 syndromic deaf-
ness genes were also included in the screening in case
that any additional symptoms of syndromic deafness
were either overlooked or absent during the clinical
evaluation (see discussion below on USH2A mutations
and Usher Syndrome type 2A). We focused on the pre-
sumably rare deafness genes by pre-exclusion of muta-
tions in three commonly screened deafness genes GJB2,
SLC26A4 and MT-RNR1. A strict criterion was applied to
identify the possible pathogenic mutations including limit-
ing the candidate mutations only to those with allele fre-
quencies of 0.0025 or lower (based on our in-house
sequencing data of 200 ethnically-matched normal hear-
ing controls), recognizing only the bi-allelic variants as
candidate recessive mutations, confirming the genotype-
phenotype co-segregation with extended family members
of the multiplex probands, and using a variety of analysis
programs to predict the effects of the candidate mutations.
Consistent with our presumptions of the heterogeneity
and the low mutation frequencies of the less commonly
screened deafness genes, our targeted NGS screening
identified a wide range of dominant, recessive and mito-
chondrial mutations in 20 deafness genes, whereas no
individual gene had mutation detection rate over 3%.
Overall, however, those less commonly screened deaf-
ness genes contributed to 17.4% (33/190) of causes in
our deaf probands, illustrating the importance of genetic
testing in those genes.
Several limitations need to be noted when interpreting
our results. First, the majority of the probands were
recruited through genetic testing and counseling of pa-
tients with hereditary hearing loss, which may lead to
over-representation of the multiplex probands (27.9% in
Figure 1 Pedigrees and the identified mutations of the deaf families (Dominant: D372, D385, D882, P59, NT01, K11 and F9;
mitochondrial inherited: D1037; consanguineous: D804 and C12). Probands of each family were pointed by the arrows.
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The percentages of the identified genetic causes, there-
fore, may be slightly over-represented accordingly. Se-
cond, our mutation identification criteria selected only
the bi-allelic variants as the candidate recessive muta-
tions. It was possible that a small number of probands
with mono-allelic mutations may have another undis-
closed mutation in the untargeted regions of the genes
such as the introns or the regulatory regions, resultingin slight under-representation of the identified genetic
causes. Third, mutations in USH2A were associated with
Usher Syndrome type 2A, a syndromic form of deafness
characterized by congenital deafness and later develop-
ment of progressive retinitis pigmentosa (RP). Because
of the late onset of RP (usually postpubertal) in Usher
Syndrome type 2A patients, it was not surprising that
we identified bi-allelic USH2A mutations in three “non-
syndromic” deaf probands, all under 6 years old.























c.6306_6307insG p.A2104CfsX18 - DCc - - 0 Novel
Missense c.8183G>A p.R2728H 3.17 DC DC(−4.66) DC (0.008) 0 Reported [8]
D768 MYO15A Splicing site c.6956+9C>G - - - - - 0 Novel
In-frame indel c.10251_10253 p.F3420del - DC DC (−10.02) - 0 Novel
delCTT
D856 MYO15A Missense c.8324G>A p.R2775H 5.89 DC DC (−4.56) DC (0.000) 0 Novel
Nonsense c.8767C>T p.R2923X 1.323 DC - - 0 Novel
D37* MYO15A Missense c.6340G>A p.V2114M 2.138 DC DC (−2.70) DC (0.041) 0 Novel
Splicing site c.6956+9C>G - - - - - 0 Novel
D465 MYO15A Missense c.3026C>A p.P1009H 0.29 POd DC(−2.47) DC (0.010) 0 Novel
c.3026C>A p.P1009H
D475 USH2A Missense c.188G>A p.R63Q 0.422 PO DC (−1.30) PO (0.260) 0 Novel
Missense c.8342C>T p.T2781I 1.606 PO DC (−3.02) PO (0.179) 0 Novel
D538 USH2A Missense c.5017C>T p.L1673F 2.504 DC DC(−2.27) DC (0.014) 0 Novel
Missense c.7076T>C p.L2359S 3.941 PO DC (−3.57) DC (0.002) 0 Novel
D773* USH2A Frame-shift
indel
c.1992_1993insT p.K665X - DC - - 0 Novel
Splicing site c.9570+1G>A - - - - - 0 Novel
D121 PCDH15 Missense c.1286T>C p.L429P 4.774 DC DC (−3.46) DC (0.019) 0 Novel
c.1286T>C p.L429P
D884* PCDH15 Missense c.3862T>C p.S1288P 4.99 DC DC(−2.33) DC (0.010) 0 Novel
Missense c.4118C>T p.T1373I 4.488 DC DC (−2.99) DC (0.002) 0 Novel
D349* PCDH15 Frame-shift
indel
1438delT p.S480RfsX1 - DC - - 0 Novel
Missense c.4118C>T p.T1373I 4.488 DC DC (−2.99) DC (0.002) 0 Novel
C5 GPR98 Frame-shift
indel
c.1379delA p.Q462RfsX36 - - - - 0 Novel
Frame-shift
indel
c.4878_4879ins p.A1630IfsX1 - - - - 0 Novel
TTTGCTAATA
D593* GPR98 Missense c.6559A>G p.I2187V 0.679 DC PO (−0.73) DC (0.041) 0 Novel
c.6559A>G p.I2187V
D29* GPR98 Missense c.2399G>A p.R800Q 5.497 DC DC(−2.680) DC (0.000) 0 Novel
Frame-shift
indel
c.10088_10091 p.V3363DfsX10 - - - - 0 Novel
delTAAG
D472 TMC1 Splicing site c.236+1G>C - - - - - 0 Novel
Missense 1334G>A p.R445H 6.306 DC DC (−4.97) DC (0.000) 0 Reported [15]
D419 TMC1 Frame-shift
indel
c.150delT p.N50KfsX25 - - - - 0 Reported [16]
Missense c.1107C>A p.N369K 2.211 DC DC (−5.76) DC (0.001) 0 Novel
D555 TMC1 Missense c.1209G>C p.W403C 6.376 DC DC (−8.97) DC (0.000) 0 Novel
c.1209G>C p.W403C
D433 CDH23 Missense c.2752G>C p.D918H 6.036 DC DC (−5.49) DC (0.000) 0 Novel
Missense c.6606C>A p.D2202E 3.482 DC DC (−2.90) DC (0.013) 0 Novel
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Table 3 Bi-allelic mutations identified in recessive deaf probands (Continued)
D32* CDH23 Missense c.7630T>G p.L2544V 0.393 DC PO (−0.54) PO (0.404) 0 Novel
Missense c.8257G>A p.A2753T 5.768 DC DC (−1.40) DC (0.011) 0 Novel
D111 OTOF Nonsense c.4225A>T p.K1409X 1.376 DC - - 0 Novel
Splicing site c.4961-3C>G - - - - - 0 Novel
D364 MYO7A In-frame indel c.1923_1931del p.KKP642_644del >1.783 PO DC (−25.72) - 0 Novel
CAAGAAGCC
Nonsense c.6049C>T p.Q2017X 5.211 DC - - 0 Novel
D499 ESRRB Missense c.1144C>T p.R382C 6.124 DC DC (−3.01) DC (0.039) 0 Novel
Missense c.1171T>C p.L424P 4.995 DC DC (−6.73) DC (0.002) 0 Novel
D887 MARVELD2 Frame-shift
indel
c.1221_1222 p.E408SfsX1 - DC - - 0 Novel
delAG
Splicing site c.1332-2A>G - - - - - 0 Novel
D715 TECTA Nonsense c.990C>A p.Y330X 2.723 DC - - 0 Novel
c.990C>A p.Y330X
C14 WHRN Missense c.1292G>A p.R431Q 4.083 DC DC (−2.12) DC (0.010) 0 Novel
Missense c.2542A>G p.R848G 0.487 DC DC(−1.99) DC (0.030) 0 Novel
D386 MYO6 Missense c.734A>G p.Y245C 4.416 DC DC (−8.77) DC (0.001) 0 Novel
Missense c.1015C>T p.R339W 1.35 DC DC (−4.36) DC (0.003) 0 Novel
D360* PTPRQ Missense c.5786G>C p.R1929T 2.965 DC DC (−2.38) DC (0.023) 0 Novel
Nonsense c.6226C>T p.Q2076X 5.726 DC - - 0 Novel
D366* POU3F4 Frame-shift
indel
c.644_645insG p.L217VfsX8 - DC - - 0 Novel
c.644_645insG p.L217VfsX8
*Multiplex probands with bi-allelic variants also detected in their deaf relatives; aScore ranges from −14 (not conserved) to 6 (conserved); bNegative and positive
scores indicated deleterious and neutral function, respectively, with cut-off score set at −1.3; cScore ranges from 0 (deleterious) to 1 (neutral), with cut-off score
set at 0.05; cDC: Disease causing; dPO: Polymorphism.
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view of the genetic etiology of non-syndromic deafness
in Chinese Hans (Figure 2). In addition to GJB2,
SLC26A4 and MT-RNR1, a variety of less commonly
screened deafness genes accounted for a significant por-
tion of genetic causes of non-syndromic deafness. A
total of 53 different types of mutations in 20 deafness
genes were identified, with 48 of them being novel. OurFigure 2 Estimates of genetic causes of non-syndromic deafness in Cresults confirmed the effectiveness of the targeted NGS
screening of the known deafness genes.
Interestingly, our comprehensive screening of 79 deaf-
ness genes did not identify any pathogenic mutations in
three dominant families and two consanguineous fa-
milies (Figure 1). We postulated that hearing impairment
in these families was likely to be caused by mutations in
novel deafness genes and warranted further studies byhinese Hans based on our study.
Yang et al. Orphanet Journal of Rare Diseases 2013, 8:85 Page 8 of 8
http://www.ojrd.com/content/8/1/85linkage analysis and/or whole-exome sequencing. Used
as a complementary step, this pre-exclusion strategy
against known deafness genes may facilitate the discovery
of novel deafness genes.
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